Deal History
Om oss
Om oss
Team
Våra kontor
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Skuldrådgivning
Equity Research
Tillväxtkapital
IPO Advisory
Industries
Företagstjänster
Internet och konsumentprodukter
Industri och verkstad
Sjuk- och hälsovård
Mjukvara och TMT
Research
Analysmaterial
Makro och marknad
Career
Events
Insights
News
Bolagsnyheter
Deal News
I pressen
Newsletter
Kontakt
Newsletter
SV
INT
DA
DE
FR
Main menu button
Team
Deals
Kontakt
Aktieanalys
Team
Deals
Kontakt
Nyheter
Alla
Analysmaterial
Bolagsnyheter
Deal News
Events
I pressen
Insights
Makro och marknad
Alla
Abera Bioscience
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Alzinova
Angler Gaming
Arctic Minerals
Bentley Endovascular Group
Biosergen
Biovica
Boozt
Candles Scandinavia
Cantargia
Carlsquare
CDON
CellaVision
CSAM Health Group
edyoutec
Elicera Therapeutics
Enrad
Fable Media
Frequentis
Future Gaming
GHP Specialty Care
Gubra
H&D Wireless
Hansa Biopharma
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Lokotech
Medclair Invest
Medivir
Midsummer
Modus Therapeutics
Moninvent
NeoDynamics
Nexam Chemical
Nischer Properties
Nodebis
Nosa Plugs
Observit
Odinwell
Orion Corporation
Pila Pharma
Prolight Diagnostics
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
Alla
12 feb 2026
Equity research Candles Scandinavia Q4 2025: Sustained double-digit growth
Analysmaterial
Candles Scandinavia
11 feb 2026
Analys Nodebis, kv4 2025: Starkt operativt KF under ett annars svalt kvartal
Analysmaterial
Nodebis
11 feb 2026
Equity research Candles Scandinavia: First impression Q4 2025 - Strong growth confirmed
Analysmaterial
Candles Scandinavia
09 feb 2026
Preview Angler Gaming, kv4 2025: Fortsatt marginalförbättring i korten
Analysmaterial
Angler Gaming
09 feb 2026
Analys ALM Equity, kv4 2025: Fokus på expansivt förvärv
Analysmaterial
ALM Equity
04 feb 2026
Analys Nodbis: Fortsatt hög tillväxt och förbättrade marginaler under kv4
Analysmaterial
Nodebis
02 feb 2026
Analys KlaraBo, kv4 2025: Fokus på lägenhetsrenoveringar och räntenivå
Analysmaterial
KlaraBo
29 jan 2026
Analys Zinzino: Preview kv4 2025 - M&A lyfter försäljningsprognosen
Analysmaterial
Zinzino
26 jan 2026
Analys KlaraBo: Ännu en fastighetsaffär som ökar fokus i portföljen
Analysmaterial
KlaraBo
23 jan 2026
Equity research Viva Wine Group: A first step into the NoLo category
Analysmaterial
Viva Wine Group
22 jan 2026
Equity research CDON: Preview , Q4 2025 - GMV growth and earnings increase
Analysmaterial
CDON
20 jan 2026
Equity research White Pearl Technology Group, Q4 2025: Revised estimates post solid preliminary sales figures
Analysmaterial
White Pearl Technology Group
20 jan 2026
Equity research Viva Wine Group: Preview Q4 2025 - Profit growth from acquisition and margin recovery
Analysmaterial
Viva Wine Group
09 jan 2026
Analys Elicera Therapeutics: Klinisk uppdatering om ELC-100 i linje med våra förväntningar
Analysmaterial
Elicera Therapeutics
22 dec 2025
Analys ALM Equity: Förvärv av Storstaden visar på framtidstro
Analysmaterial
ALM Equity
17 dec 2025
Analys KlaraBo: Bytesaffär med Sveafastigheter ger stordriftsfördelar
Analysmaterial
KlaraBo
09 dec 2025
Equity research White Pearl Technology Group: M&A and new business support growth outlook
Analysmaterial
White Pearl Technology Group
08 dec 2025
Analys Svenska Aerogel: Största kommersiella ordern hittills
Analysmaterial
Svenska Aerogel
05 dec 2025
Equity research Candles Scandinavia, Q3 2025/26: Solid growth, synergies underpin 2026 outlook
Analysmaterial
Candles Scandinavia
04 dec 2025
Equity research Candles Scandinavia Q2 2025/26: First impression - Solid growth, integration hampers margins in the short-term
Analysmaterial
Candles Scandinavia
1
2
3
4
5
6
…
85